The investment round was led by existing backers including Sony Innovation Fund.
"We have built a great relationship with our investors, who fully back our mission of using technology to make insurance fairer, and doing so in a sustainable way."
Sony Innovation Fund joins the second close of the funding round to support the development of silicon-based quantum computers.
"We are actively exploring investments in technologies that will be transformational with wide ranging applications. Quantum computing has the potential to have that impact, and we want to work with the companies that are best positioned to bring it to commercial scale. As our first investment in the quantum technologies space, Quantum Motion is already demonstrating tremendous advancement and leadership, and we are excited to help fuel their next stage of growth."
Base10 Partners led the round to support platform development and international expansion.
"While working in fashion, it became clear to me that e-commerce was the future, but 2D websites were merely a tool that enabled an online purchase, but were lacking the customer journey and story-telling that brands are after. The solution was to bridge that gap, with the aim of making virtual experiences into the future of brands’ long-term e-commerce strategy."
AlbionVC led the Series B round to fund the digital health platform's expansion into the American market.
"We’re on a mission to become a household name across the world and our Series B funding is just the start. We already dominate Europe’s employer-funded gender-based healthcare market. With our growing team in the US and numerous big brands already choosing Peppy, we will soon be a leading player in America."
The financing round was led by Lytical Ventures with participation from Flashpoint and Sony Innovation Fund.
"We got pulled to the US market and saw a significant demand for our solution in the financial services sector. With this funding round we are increasing our sales and marketing efforts on the US and European markets. And we are also continuing to invest in our technical and product capabilities to automate compliance workflows and apply our data science models to the compliance content as one of the biggest challenges that heavily regulated firms are facing is keeping up with the volume of regulatory change."
Morningside led the Series B financing to support regulatory approvals and market entry for clinical software treatments.
"At ieso, we’re looking to transform global mental health by unlocking the power of clinical data to develop AI-enabled digital therapeutics. Our experience delivering outstanding mental health care within the NHS ideally places us for starting to tackle this challenge. A new generation of clinically-validated digital mental health care products could ultimately improve millions of lives. But we cannot do this alone, and look forward to working with our patients, clinicians, investors, as well as existing and future partners, to better serve those who require mental health support."